Archer-Daniels-Midland Company
Global agribusiness giant that restated six years of segment financials following an SEC probe into improper intersegment transfers boosting Nutrition profits.
- Entity Name: Archer-Daniels-Midland Company
- Country of Domicile: US
- Listing & Ticker: NYSE (ADM).
- CIK / LEI Identifier: 0000007084.
- Industry Classification: Fats, Oils, and Agribusiness (SIC 2070).
- Cumulative Overstatement: $400.0M across 1 enforcement episode(s).
- Assessed Penalties: $0.
PRIMARY ENFORCEMENT CASES INVOLVING ARCHER-DANIELS-MIDLAND COMPANY
1 CASE DOSSIERS| Case Title | Status | Primary Scheme | Overstatement | Total Penalties | Action Date |
|---|---|---|---|---|---|
| Archer Daniels Midland: Intersegment Transfer Pricing & Nutrition Margin Shift | Ongoing Proceedings | segment misreporting | $400.0M | $0 | September 20, 2025 |
FORENSIC PROFILE: ARCHER DANIELS MIDLAND: INTERSEGMENT TRANSFER PRICING & NUTRITION MARGIN SHIFT
FULL CASE DOSSIER →Restated six years of intersegment sales after internal audit and SEC probes uncovered improper transfer pricing shifting operating profits into the high-growth Nutrition segment.
The company manipulated its accounting records by executing schemes under segment-misreporting. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.
Fraud Window: January 1, 2024 to December 31, 2025 • Primary Regulator: U.S. Securities and Exchange Commission • Auditor: Ernst & Young LLP
Documented Accounting Irregularities & Regulatory Findings
- SEGMENT MISREPORTING: Restated six years of intersegment sales after internal audit and SEC probes uncovered improper transfer pricing shifting operating profits into the high-growth Nutrition segment.
Primary Public Dockets & Actions
- [ENF-2024-adm] Enforcement Action: Archer Daniels Midland: Intersegment Transfer Pricing & Nutrition Margin Shift (September 20, 2025): Restated six years of intersegment sales after internal audit and SEC probes uncovered improper transfer pricing shifting operating profits into the high-growth Nutrition segment. Official Record ↗